Phosphorylation of the C-Raf N Region Promotes Raf Dimerization.

Area of Science:

• Cellular signaling pathways
• Cancer biology
• Protein phosphorylation

Background:

• Raf kinases, activated by Ras GTPase, require specific phosphorylations for activation.
• N-region phosphorylations on C-Raf, including serine 338 (S338) and tyrosine 341 (Y341), are implicated in allosteric activation of Raf dimers.

Purpose of the Study:

• To investigate the role of N-region phosphorylations in C-Raf activation and dimerization.
• To determine the sequence of N-region phosphorylation events relative to C-Raf dimerization.
• To explore the therapeutic potential of targeting C-Raf Y341 phosphorylation in Ras-driven cancers.

Main Methods:

• In vivo and in vitro experiments using phosphomimetic mutants.
• Analysis of C-Raf phosphorylation and dimerization in Ras mutant pancreatic cancer cell lines.
• Inhibition studies using Src family inhibitors.

Main Results:

• N-region site phosphorylations precede C-Raf dimerization.
• Phosphorylation of Y341 (pY341) is essential for C-Raf dimerization and can be mimicked by phosphomimetic mutants.
• pY341 phosphorylation promotes C-Raf dimerization independently of S338 phosphorylation.
• Basal C-Raf phosphorylation and dimerization are elevated in Ras mutant pancreatic cancer cells.
• Src family inhibitors block C-Raf growth, dimerization, and ERK activation in these cells.

Conclusions:

• C-Raf Y341 phosphorylation is a key driver of C-Raf dimerization and subsequent MAPK/ERK pathway activation in Ras-dependent cancers.
• Targeting the kinases responsible for C-Raf Y341 phosphorylation represents a promising therapeutic strategy for specific cancers.